W
Whitehawk Therapeutics, Inc. (WHWK)
NCM – Real Time Price. Currency in USD
3.92
+0.12 (3.16%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.92
+0.12 (3.16%)
At close: May 12, 2026, 4:00 PM EDT
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
| Name | Position |
|---|---|
| Dr. David Dornan Ph.D. | Chief Scientific Officer |
| Dr. David J. Lennon Ph.D. | President, CEO & Director |
| Dr. Margaret Han Dugan M.D. | Chief Medical Officer |
| Dr. Neil P. Desai Ph.D. | Founder & Director |
| Mr. Bryan Ball | Chief Technical Operations Officer |
| Mr. Scott M. Giacobello CPA | CFO, Treasurer, Investor Relations & Corporate Communications |
| Mr. Stephen M. Rodin J.D. | Senior VP of Legal & General Counsel |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | whwk-20260507.htm |
| 2026-05-07 | 10-Q | whwk-20260331.htm |
| 2026-04-28 | DEFA14A | whwk-20260428.htm |
| 2026-04-28 | DEF 14A | whwk-20260428.htm |
| 2026-03-12 | 10-K | whwk-20251231.htm |
| 2025-11-06 | 10-Q | whwk-20250930.htm |
| 2025-08-07 | 8-K | whwk-20250807.htm |
| 2025-08-07 | 10-Q | whwk-20250630.htm |
| 2025-06-13 | 8-K | d928055d8k.htm |
| 2025-05-13 | CORRESP | filename1.htm |